{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:17:32Z","timestamp":1791944252136,"version":"4.3.4"},"reference-count":44,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.3960\/jslrt.19003","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:28:54Z","timestamp":1553639334000},"page":"1-16","source":"Crossref","is-referenced-by-count":47,"title":["High TNFRSF14 and low BTLA are associated with poor prognosis in                    Follicular Lymphoma and in Diffuse Large B-cell Lymphoma                    transformation"],"prefix":"10.3960","volume":"59","author":[{"given":"Joaquim","family":"Carreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Lopez-Guillermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara Yukie","family":"Kikuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johbu","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyaoka","family":"Masashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Hiraiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Leich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Villamor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis","family":"Colomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko M","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Carreras                            J,                                Lopez-Guillermo                            A,                                Fox                            BC                    <i>et al.<\/i> High numbers of tumor-infiltrating FOXP3-positive                    regulatory T cells are associated with improved overall survival in follicular                    lymphoma. Blood. 2006; 108: 2957-2964.","DOI":"10.1182\/blood-2006-04-018218"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Martinez                            A,                                Carreras                            J,                                Campo                            E. The                    follicular lymphoma microenvironment: from tumor cell to host immunity. Curr                    Hematol Malig Rep. 2008; 3: 179-186.","DOI":"10.1007\/s11899-008-0026-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Carreras                            J,                                Lopez-Guillermo                            A,                                Roncador                            G                    <i>et al.<\/i> High numbers of tumor-infiltrating programmed cell death                    1-positive regulatory lymphocytes are associated with improved overall survival                    in follicular lymphoma. J Clin Oncol. 2009; 27: 1470-1476.","DOI":"10.1200\/JCO.2008.18.0513"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Solal-C\u00e9ligny                            P,                                Roy                            P,                                Colombat                            P                    <i>et al.<\/i> Follicular lymphoma international prognostic index.                    Blood. 2004; 104: 1258-1265.","DOI":"10.1182\/blood-2003-12-4434"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Zhou                            J,                                Mauerer                            K,                                Farina                            L,                                Gribben                            JG. The role of                    the tumor microenvironment in hematological malignancies and implication for                    therapy. Front Biosci. 2005; 10: 1581-1596.","DOI":"10.2741\/1642"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Solal-C\u00e9ligny                            P,                                Cahu                            X,                                Cartron                            G. Follicular                    lymphoma prognostic factors in the modern era: what is clinically meaningful?                    Int J Hematol. 2010; 92: 246-254.","DOI":"10.1007\/s12185-010-0674-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Dave                            SS,                                Wright                            G,                                Tan                            B                    <i>et al.<\/i> Prediction of survival in follicular lymphoma based on                    molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004; 351:                    2159-2169.","DOI":"10.1056\/NEJMoa041869"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Farinha                            P,                                Masoudi                            H,                                Skinnider                            BF                    <i>et al.<\/i> Analysis of multiple biomarkers shows that                    lymphoma-associated macrophage (LAM) content is an independent predictor of                    survival in follicular lymphoma (FL). Blood. 2005; 106: 2169-2174.","DOI":"10.1182\/blood-2005-04-1565"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Clear                            AJ,                                Lee                            AM,                                Calaminici                            M                    <i>et al.<\/i> Increased angiogenic sprouting in poor prognosis FL is                    associated with elevated numbers of CD163+ macrophages within the immediate                    sprouting microenvironment. Blood. 2010; 115: 5053-5056.","DOI":"10.1182\/blood-2009-11-253260"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Nishikawa                            H,                                Sakaguchi                            S. Regulatory T                    cells in cancer immunotherapy. Curr Opin Immunol. 2014; 27: 1-7.","DOI":"10.1016\/j.coi.2013.12.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Farinha                            P,                                Al-Tourah                            A,                                Gill                            K                    <i>et al.<\/i> The architectural pattern of FOXP3-positive T cells in                    follicular lymphoma is an independent predictor of survival and histologic                    transformation. Blood. 2010; 115: 289-295.","DOI":"10.1182\/blood-2009-07-235598"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Salmaninejad                            A,                                Khoramshahi                            V,                                Azani                            A                    <i>et al.<\/i> PD-1 and cancer: molecular mechanisms and polymorphisms.                    Immunogenetics. 2018; 70: 73-86.","DOI":"10.1007\/s00251-017-1015-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Wahlin                            BE,                                Aggarwal                            M,                                Montes-Moreno                            S                    <i>et al.<\/i> A unifying microenvironment model in follicular                    lymphoma: outcome is predicted by programmed death-1--positive, regulatory,                    cytotoxic, and helper T cells and macrophages. Clin Cancer Res. 2010; 16:                    637-650.","DOI":"10.1158\/1078-0432.CCR-09-2487"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Rodriguez-Barbosa                            JI,                                Fernandez-Renedo                            C,                                Moral                            AMB,                                B\u00fchler                            L, del                                Rio                            ML. T follicular                    helper expansion and humoral-mediated rejection are independent of the HVEM\/BTLA                    pathway. Cell Mol Immunol. 2017; 14: 497-510.","DOI":"10.1038\/cmi.2015.101"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Pasero                            C,                                Olive                            D. Interfering                    with coinhibitory molecules: BTLA\/HVEM as new targets to enhance anti-tumor                    immunity. Immunol Lett. 2013; 151: 71-75.","DOI":"10.1016\/j.imlet.2013.01.008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Gavrieli                            M,                                Sedy                            J,                                Nelson                            CA,                                Murphy                            KM. BTLA and                    HVEM cross talk regulates inhibition and costimulation. Adv Immunol. 2006; 92:                    157-185.","DOI":"10.1016\/S0065-2776(06)92004-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Murphy                            TL,                                Murphy                            KM. Slow down                    and survive: enigmatic immunoregulation by BTLA and HVEM. Annu Rev Immunol.                    2010; 28: 389-411.","DOI":"10.1146\/annurev-immunol-030409-101202"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Shang                            Y,                                Guo                            G,                                Cui                            Q                    <i>et al.<\/i> The expression and anatomical distribution of BTLA and                    its ligand HVEM in rheumatoid synovium. Inflammation. 2012; 35: 1102-1112.","DOI":"10.1007\/s10753-011-9417-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kotsiou                            E,                                Okosun                            J,                                Besley                            C                    <i>et al.<\/i> TNFRSF14 aberrations in follicular lymphoma increase                    clinically significant allogeneic T-cell responses. Blood. 2016; 128: 72-81.","DOI":"10.1182\/blood-2015-10-679191"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Ren                            S,                                Tian                            Q,                                Amar                            N                    <i>et al.<\/i> The immune checkpoint, HVEM may contribute to immune                    escape in non-small cell lung cancer lacking PD-L1 expression. Lung Cancer.                    2018; 125: 115-120.","DOI":"10.1016\/j.lungcan.2018.09.004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Campo                            E,                                Swerdlow                            SH,                                Harris                            NL                    <i>et al.<\/i> The 2008 WHO classification of lymphoid neoplasms and                    beyond: evolving concepts and practical applications. Blood. 2011; 117:                    5019-5032.","DOI":"10.1182\/blood-2011-01-293050"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kawashima                            T,                                Kosaka                            A,                                Yan                            H                    <i>et al.<\/i> Double-stranded RNA of intestinal commensal but not                    pathogenic bacteria triggers production of protective interferon-\u03b2. Immunity.                    2013; 38: 1187-1197.","DOI":"10.1016\/j.immuni.2013.02.024"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Aguirre-Gamboa                            R,                                Gomez-Rueda                            H,                                Mart\u00ednez-Ledesma                            E                    <i>et al.<\/i> SurvExpress: an online biomarker validation tool and                    database for cancer gene expression data using survival analysis. PLoS One.                    2013; 8: e74250.","DOI":"10.1371\/journal.pone.0074250"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Subramanian                            A,                                Tamayo                            P,                                Mootha                            VK                    <i>et al.<\/i> Gene set enrichment analysis: A knowledge-based approach                    for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;                    102: 15545-15550.","DOI":"10.1073\/pnas.0506580102"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Mootha                            VK,                                Lindgren                            CM,                                Eriksson                            KF                    <i>et al.<\/i> PGC-1\u03b1-responsive genes involved in oxidative                    phosphorylation are coordinately downregulated in human diabetes. Nat Genet.                    2003; 34: 267-273.","DOI":"10.1038\/ng1180"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Budczies                            J,                                Klauschen                            F,                                Sinn                            BV                    <i>et al.<\/i> Cutoff Finder: a comprehensive and straightforward Web                    application enabling rapid biomarker cutoff optimization. PLoS One. 2012; 7:                    e51862.","DOI":"10.1371\/journal.pone.0051862"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Mesin                            L,                                Ersching                            J,                                Victora                            GD. Germinal                    Center B Cell Dynamics. Immunity. 2016; 45: 471-482.","DOI":"10.1016\/j.immuni.2016.09.001"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Muramatsu                            M,                                Kinoshita                            K,                                Fagarasan                            S                    <i>et al.<\/i> Class switch recombination and hypermutation require                    activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.                    Cell. 2000; 102: 553-563.","DOI":"10.1016\/S0092-8674(00)00078-7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Victora                            GD,                                Dominguez-Sola                            D,                                Holmes                            AB                    <i>et al.<\/i> Identification of human germinal center light and dark                    zone cells and their relationship to human B-cell lymphomas. Blood. 2012; 120:                    2240-2248.","DOI":"10.1182\/blood-2012-03-415380"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Victora                            GD,                                Schwickert                            TA,                                Fooksman                            DR                    <i>et al.<\/i> Germinal center dynamics revealed by multiphoton                    microscopy with a photoactivatable fluorescent reporter. Cell. 2010; 143:                    592-605.","DOI":"10.1016\/j.cell.2010.10.032"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Chtanova                            T,                                Tangye                            SG,                                Newton                            R                    <i>et al.<\/i> T follicular helper cells express a distinctive                    transcriptional profile, reflecting their role as non-Th1\/Th2 effector cells                    that provide help for B cells. J Immunol. 2004; 173: 68-78.","DOI":"10.4049\/jimmunol.173.1.68"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Gaulard                            P, de                                Leval                            L. Follicular                    helper T cells: implications in neoplastic hematopathology. Semin Diagn Pathol.                    2011; 28: 202-213.","DOI":"10.1053\/j.semdp.2011.03.003"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 M\u2019Hidi                            H,                                Thibult                            ML,                                Chetaille                            B                    <i>et al.<\/i> High expression of the inhibitory receptor BTLA in                    T-follicular helper cells and in B-cell small lymphocytic lymphoma\/chronic                    lymphocytic leukemia. Am J Clin Pathol. 2009; 132: 589-596.","DOI":"10.1309\/AJCPPHKGYYGGL39C"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Kashiwakuma                            D,                                Suto                            A,                                Hiramatsu                            Y                    <i>et al.<\/i> B and T lymphocyte attenuator suppresses IL-21                    production from follicular Th cells and subsequent humoral immune responses. J                    Immunol. 2010; 185: 2730-2736.","DOI":"10.4049\/jimmunol.0903839"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Pangault                            C,                                Am\u00e9-Thomas                            P,                                Ruminy                            P                    <i>et al.<\/i> Follicular lymphoma cell niche: identification of a                    preeminent IL-4-dependent TFH\u2013B cell axis. Leukemia. 2010; 24: 2080-2089.","DOI":"10.1038\/leu.2010.223"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Steinberg                            MW,                                Cheung                            TC,                                Ware                            CF. The                    signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune                    regulation. Immunol Rev. 2011; 244: 169-187.","DOI":"10.1111\/j.1600-065X.2011.01064.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Cheung                            TC,                                Steinberg                            MW,                                Oborne                            LM                    <i>et al.<\/i> Unconventional ligand activation of herpesvirus entry                    mediator signals cell survival. Proc Natl Acad Sci USA. 2009; 106: 6244-6249.","DOI":"10.1073\/pnas.0902115106"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 del                                Rio                            ML,                                Lucas                            CL,                                Buhler                            L,                                Rayat                            G,                                Rodriguez-Barbosa                            JI.                    HVEM\/LIGHT\/BTLA\/CD160 cosignaling pathways as targets for immune regulation. J                    Leukoc Biol. 2010; 87: 223-235.","DOI":"10.1189\/jlb.0809590"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Hu                            X,                                Baytak                            E,                                Li                            J                    <i>et al.<\/i> The relationship of REL proto-oncogene to pathobiology                    and chemoresistance in follicular and transformed follicular lymphoma. Leuk Res.                    2017; 54: 30-38.","DOI":"10.1016\/j.leukres.2017.01.001"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Cheung                            KJJ,                                Johnson                            NA,                                Affleck                            JG                    <i>et al.<\/i> Acquired TNFRSF14 mutations in follicular lymphoma are                    associated with worse prognosis. Cancer Res. 2010; 70: 9166-9174.","DOI":"10.1158\/0008-5472.CAN-10-2460"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Boice                            M,                                Salloum                            D,                                Mourcin                            F                    <i>et al.<\/i> Loss of the HVEM Tumor Suppressor in Lymphoma and                    Restoration by Modified CAR-T Cells. Cell. 2016; 167: 405-418.e13.","DOI":"10.1016\/j.cell.2016.08.032"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Zhao                            DM,                                Thornton                            AM,                                DiPaolo                            RJ,                                Shevach                            EM. Activated                    CD4+CD25+ T cells selectively kill B lymphocytes. Blood. 2006; 107: 3925-3932.","DOI":"10.1182\/blood-2005-11-4502"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Farhood                            B,                                Najafi                            M,                                Mortezaee                            K. CD8+                    cytotoxic T lymphocytes in cancer immunotherapy: A review. J Cell Physiol. 2019;                    234: 8509-8521.","DOI":"10.1002\/jcp.27782"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Murphy                            KM,                                Nelson                            CA,                                \u0160ed\u00fd                            JR. Balancing                    co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol. 2006; 6:                    671-681.","DOI":"10.1038\/nri1917"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/59\/1\/59_19003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T04:23:07Z","timestamp":1558758187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/59\/1\/59_19003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.19003","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}